Replay available

BillionToOne, Inc. (BLLN) Q1 2026 Earnings Call

BillionToOne, Inc. (NASDAQ: BLLN) Q1 2026 earnings conference call, held 2026-05-06. Replay captured from the company's public earnings webcast.

Wed, May 6, 2026 at 4:30 PMendedReplay
BillionToOne, Inc. (BLLN) Q1 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

David Deichler

Investor Relations

Ozan Tay

Co-founder & Chief Executive Officer

Ross Taylor

Chief Financial Officer

Andrew Brackman

Analyst, William Blair

Dan Aries

Analyst, Stifel

Mark Massaro

Analyst, BTIG

Saboon Nambi

Analyst, Guggenheim

Sebastian Sandler

Analyst, JPMorgan

Brendan Cuyana

Analyst, Wells Fargo

Tycho Peterson

Analyst, Jefferies

Replay transcript excerpt

Thank you for standing by and welcome to the Billion to One First Quarter 2026 Earnings Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during this session, you'll need to press star 11 on your telephone. If your question has been answered and you'd like to remove yourself from the queue, simply press star 11 again. As a reminder, today's program is being recorded. And now I'd like to introduce your host for today's program, David Deichler, Investor Relations. Please go ahead, sir. Good afternoon, everyone. Thank you for participating in today's conference call. Joining me on the call from Billion to One, we have Ozana Tay, co-founder and chief executive officer, and Ross Taylor, chief financial officer. Earlier today, Billion to One released financial results for the first quarter ended March 31st, 2026. A copy of the press release is available on the company's website. Before we begin, I want to remind you that during this call, we may make forward-looking statements within the meaning of federal securities laws. Such statements about future events may include statements about our financial outlook and performance, market size, our products and services, reimbursement coverage, future clinical performance, and other similar statements. We caution you that such statements reflect our current best judgment and actual results may differ materially from those expressed or implied in any forward-looking statements. Risk factors that may cause our results to differ are discussed in our filings with the SEC, including our previously filed annual report, Form 10-K, our quarterly report on Form 10-Q to be filed following this call, and the current report on Form 8-...

More from Billiontoone, Inc.